IVUS and iFR technologies receive top-level recognition in new ESC Guidelines, reinforcing their role in optimizing coronary interventions and patient outcomes
Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
What's trending
News
IVUS and iFR technologies receive top-level recognition in new ESC Guidelines, reinforcing their role in optimizing coronary interventions and patient outcomes
Click here to learn moreJackson Health System projects 47% reduction in carbon emissions from patient monitors with Philips next generation monitoring platform
Click here to learn morePhilips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology
Click here to learn more